Hepatoblastoma clinical trials at UCSF
1 in progress, 0 open to new patients
Sorry, in progress, not accepting new patients
This phase II trial is studying the side effects of and how well alisertib works in treating young patients with relapsed or refractory solid tumors or leukemia. Alisertib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
San Francisco, California and other locations